Results 261 to 270 of about 112,556 (314)

Reconstructing EBV reactivation and DNA damage response kinetics in morphologic pseudotime. [PDF]

Proc Natl Acad Sci U S A
Tekle DG, Dobry CJ, Sexton JZ, SoRelle ED.   +3 more
europepmc   +1 more source

Issue Information

Veterinary Record Open, Volume 13, Issue 2, December 2026.
wiley   +1 more source

Early imaging differentiation of children with acute hematologic malignancies that present in pancytopenia: a retrospective study. [PDF]

Front Oncol
Ma J, Wang Y, Xu Y, He Y, Zhang X, Li J, Gao S, Ma W, Dai D.   +8 more
europepmc   +1 more source

Some of the next articles are maybe not open access.

Related searches:

The roles of EBV-encoded microRNAs in EBV-associated tumors

Critical Reviews in Oncology/Hematology, 2019
Epstein-Barr virus (EBV) is believed to be a pathogen causing a number of human cancers, but the pathogenic mechanisms remain unclear. An increasing number of studies have indicated that EBV-encoded microRNAs (EBV miRNAs) are expressed in a latency type- and tumor type-dependent manner, playing important roles in the development and progression of EBV ...
Jian-Ning Chen, Li-Ping Gong, Chun-Kui Shao   +2 more
exaly   +3 more sources

EBV and Autoimmunity

2015
Although a role of EBV in autoimmunity is biologically plausible and evidence of altered immune responses to EBV is abundant in several autoimmune diseases, inference on causality requires the determination that disease risk is higher in individuals infected with EBV than in those uninfected and that in the latter it increases following EBV infection ...
Alberto, Ascherio, Kassandra L, Munger
openaire   +2 more sources

Immune defence against EBV and EBV-associated disease

Current Opinion in Immunology, 2011
Epstein-Barr virus (EBV), a B-lymphotropic herpesvirus widespread in the human population and normally contained as an asymptomatic infection by T cell surveillance, nevertheless causes infectious mononucleosis and is strongly linked to several types of human cancer. Here we describe new findings on the range of cellular immune responses induced by EBV
Heather M, Long, Graham S, Taylor, Alan B, Rickinson   +2 more
openaire   +2 more sources

EBV+ lymphoproliferative diseases: opportunities for leveraging EBV as a therapeutic target

Blood, 2022
Abstract Epstein-Barr virus (EBV) is a ubiquitous human tumor virus, which contributes to the development of lymphoproliferative disease, most notably in patients with impaired immunity. EBV-associated lymphoproliferation is characterized by expression of latent EBV proteins and ranges in severity from a relatively benign proliferative ...
Keri Toner, Catherine M. Bollard
openaire   +2 more sources

EBV and Autoimmunity

Although the role of Epstein-Barr virus (EBV) in autoimmunity is biologically plausible and evidence of altered immune responses to EBV is abundant in several autoimmune diseases, inference on causality requires the determination that disease risk is higher in individuals infected with EBV than in those uninfected and that in the latter it increases ...
Marianna, Cortese, Alberto, Ascherio, Kjetil, Bjornevik   +2 more
openaire   +2 more sources

To EBV or not to EBV: Rational vaccine design for a common infection

Science Immunology, 2018
A human antibody that prevents EBV infection is identified by studying memory B cells that recognize core EBV fusion proteins.
openaire   +2 more sources